VF
DXCM icon

VitalStone Financial’s DexCom DXCM Stock Holding History

VitalStone Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$3.52K – 506
2024
Q2 		$3.52K Buy
31
+9
+41% +$1.14K ﹤0.01% 328
2024
Q1 		$3K Sell
22
-65
-75% -$8.17K ﹤0.01% 361
2023
Q4 		$11K Sell
87
-25
-22% -$2.55K 0.01% 273
2023
Q3 		$11K Buy
112
+100
+833% +$11.3K 0.01% 237
2023
Q2 		$1K Sell
12
-1
-8% -$121 ﹤0.01% 836
2023
Q1 		$7K Buy
13
+1
+8% +$112 0.01% 226
2022
Q4 		$1K Buy
+12
New +$1.32K ﹤0.01% 472

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VitalStone Financial's DXCM Position: Q3 2024 in Review

VitalStone Financial sold out of DexCom (DXCM) in Q3 2024, closing a stake of 31 shares — an estimated $3.52K sold.

VitalStone Financial first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $11K in Q4 2023. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • VitalStone Financial reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • VitalStone Financial sold 31 DexCom shares in Q3 2024, an estimated $3.52K.
  • VitalStone Financial first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • VitalStone Financial's DexCom position peaked at $11K in Q4 2023.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.